19:40

Key Insights in Chronic Lymphocytic Leukemia

HMP Education

22:23

The BCR signaling pathway in CLL

HMP Education

29:14

Ibrutinib resistance-mechanisms and options in CLL

HMP Education

24:24

The epidemiology of CLL: What do we know about risk?

HMP Education

22:08

Role of chemotherapy in CLL management

HMP Education

24:22

Highlight of CLL-related 2016 FDA approvals: Venetoclax

HMP Education

20:23

CLL: Update on approved TKIs and their use in clinical practice

HMP Education

21:05

CLL: Optimal approaches for patients with deletion 17p

HMP Education

30:43

Richter's syndrome: Update

HMP Education

14:07

Novel agents in the pipeline for CLL & lymphoma

HMP Education

26:55

New insights into the biology and treatment of Waldenström Macroglobulinemia

HMP Education